Peking union medical college hospital
Beijing, Beijing Municipality, 100730, China
NCT Number: NCT06669481
This is a retrospective observational cohort study involving patients with suspected PPGLs who underwent 131I-MIBG scanning and surgical treatment between January 2020 and April 2023. The objective is to evaluate the correlation between MIBG imaging score and intraoperative hemodynamic fluctuations.
Looking for future studies?
Notify MeAll sexes
Observational
Beijing, Beijing Municipality, 100730, China
This is a retrospective observational cohort study involving patients with suspected PPGLs who underwent 131I-MIBG scanning and surgical treatment between January 2020 and April 2023. The objective is to evaluate the correlation between MIBG imaging score and intraoperative hemodynamic fluctuations.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Patients received thyroid blockade using solution of potassium iodide before the examination. After intravenous administration of 111 MBq of 131I-MIBG, whole body planar images were acquired at 24 hours (Day 1) and 48 hours (Day 2), respectively.
Time frame: Intraoperative systolic blood pressure (SBP) and diastolic blood pressure (DBP) were recorded automatically in a 5 min interval from the beginning to the end of surgery.
Mean arterial pressure (MAP) was calculated with the formula: MAP=1/3*SBP+2/3*DBP. ARV, which was defined as the average of absolute difference between successive BP values
Peking Union Medical College Hospital
Other
Semiquantitative 131I-MIBG Scintigraphy Predicts Intraoperative Blood Pressure Fluctuation in Patients Undergoing Surgery for Pheochromocytoma and Paraganglioma
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04573816
Disease Attributes, Neoplasms
Paris, France
View Trial DetailsNCT01022515
Cardiovascular Diseases, Essential Hypertension
Lille, France
View Trial DetailsNCT04400474
Adenocarcinoma, Anaplastic Thyroid Cancer
Badalona, Barcelona, Spain
View Trial DetailsNCT00843037
Neoplasm Metastasis, Neoplasms
Calgary, Alberta, Canada
View Trial Details